PubMed · 2014 · 525 citations · 6 references
Veterinary MedicineImmunologyInfectious DiseasesImmunopathologyInflammationSepsisAcute InflammationBiomarkers In SepsisCytokine BiologySepsis DiagnosisSepsis PathophysiologySepsis PrognosisAnti-inflammatory MechanismsInflammatory Organ DamageInterleukin-mediated InflammationSepsis PathologySepsis-associated Cytokine DysregulationSepsis-associated Cytokine ResponseSepsis-associated InflammationSepsis-induced Tissue Injury
BACKGROUND: Sepsis is a deadly immunological disorder and its pathophysiology is still poorly understood. We aimed to determine if specific pro-inflammatory and anti-inflammatory cytokines can be used as diagnostic and therapeutic targets for sepsis. MATERIALS AND METHODS: Recent publications in the MEDLINE database were searched for articles regarding the clinical significance of inflammatory cytokines in sepsis. RESULTS: In response to pathogen infection, pro-inflammatory cytokines [interleukin-6 (IL-6), IL-8, IL-18 and tumor necrosis factor-α (TNF-α)] and anti-inflammatory cytokine (IL-10) increased in patients with sepsis. Importantly, a decrease in IL-6 was associated with a better prognosis and overproduction of IL-10 was found to be the main predictor of severity and fatal outcome. CONCLUSION: Both pro-inflammatory and anti-inflammatory cytokines constitute a double-edged sword in sepsis; on one hand they are critical to eliminate the infection while on the other, excessive production can cause tissue and organ damage. Increase in cytokines such as IL-6, Il-8, IL-10, IL-18 and TNF-α may have implications in diagnosis and treatment of sepsis.
6
IL-18 in autoimmunity: review.
Diana Boraschi, Charles A. Dinarello · PubMed · 2006 · 208 citations
Life Sciences, Immunology, Pathology +17
Induction of interleukin-1 and interleukin-1 receptor antagonist.
CA Dinarello · PubMed · 1997 · 64 citations